Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells

Jim Jinn Chyuan Sheu, Bin Guan, Fuu Jen Tsai, Erin Yi Ting Hsiao, Chih Mei Chen, Raquel Seruca, Tian-Li Wang, Ie Ming Shih

Research output: Contribution to journalArticle

Abstract

Although the oncogenic functions of activating BRAF mutations have been clearly demonstrated in human cancer, their roles in nontransformed epithelial cells remain largely unclear. Investigating the cellular response to the expression of mutant BRAF in nontransformed epithelial cells is fundamental to the understanding of the roles of BRAF in cancer pathogenesis. In this study, we used two nontransformed cyst108 and RK3E epithelial cell lines as models in which to compare the phenotypes of cells expressing BRAF WT and BRAF V600E. We found that transfection of the BRAF V600E, but not the BRAF WT, expression vector suppressed cellular proliferation and induced apoptosis in both cell types. BRAF V600E generated reactive oxygen species, induced DNA double-strand breaks, and caused subsequent DNA damage response as evidenced by an increased number of pCHK2 and γH2AX nuclear foci as well as the up-regulation of pCHK2, p53, and p21. Because BRAF and KRAS (alias Ki-ras) mutations have been correlated with GLUT1 up-regulation, which encodes glucose transporter-1, we demonstrated here that expression of BRAF V600E, but not BRAF WT, was sufficient to up-regulate GLUT1. Taken together, our findings provide new insights into mutant BRAF-induced oncogenic stress that is manifested by DNA damage and growth arrest by activating the pCHK2-p53-p21 pathway in nontransformed cells, while it also confers tumor-promoting phenotypes such as the up-regulation of GLUT1 that contributes to enhanced glucose metabolism that characterizes tumor cells.

Original languageEnglish (US)
Pages (from-to)1179-1188
Number of pages10
JournalAmerican Journal of Pathology
Volume180
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

DNA Breaks
Facilitative Glucose Transport Proteins
DNA Damage
Up-Regulation
Epithelial Cells
Neoplasms
Phenotype
Mutation
Double-Stranded DNA Breaks
Transfection
Reactive Oxygen Species
Cell Proliferation
Apoptosis
Glucose
Cell Line
Growth

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells. / Sheu, Jim Jinn Chyuan; Guan, Bin; Tsai, Fuu Jen; Hsiao, Erin Yi Ting; Chen, Chih Mei; Seruca, Raquel; Wang, Tian-Li; Shih, Ie Ming.

In: American Journal of Pathology, Vol. 180, No. 3, 03.2012, p. 1179-1188.

Research output: Contribution to journalArticle

Sheu, Jim Jinn Chyuan ; Guan, Bin ; Tsai, Fuu Jen ; Hsiao, Erin Yi Ting ; Chen, Chih Mei ; Seruca, Raquel ; Wang, Tian-Li ; Shih, Ie Ming. / Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells. In: American Journal of Pathology. 2012 ; Vol. 180, No. 3. pp. 1179-1188.
@article{5ea3396d6cc646d580fbd54567159370,
title = "Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells",
abstract = "Although the oncogenic functions of activating BRAF mutations have been clearly demonstrated in human cancer, their roles in nontransformed epithelial cells remain largely unclear. Investigating the cellular response to the expression of mutant BRAF in nontransformed epithelial cells is fundamental to the understanding of the roles of BRAF in cancer pathogenesis. In this study, we used two nontransformed cyst108 and RK3E epithelial cell lines as models in which to compare the phenotypes of cells expressing BRAF WT and BRAF V600E. We found that transfection of the BRAF V600E, but not the BRAF WT, expression vector suppressed cellular proliferation and induced apoptosis in both cell types. BRAF V600E generated reactive oxygen species, induced DNA double-strand breaks, and caused subsequent DNA damage response as evidenced by an increased number of pCHK2 and γH2AX nuclear foci as well as the up-regulation of pCHK2, p53, and p21. Because BRAF and KRAS (alias Ki-ras) mutations have been correlated with GLUT1 up-regulation, which encodes glucose transporter-1, we demonstrated here that expression of BRAF V600E, but not BRAF WT, was sufficient to up-regulate GLUT1. Taken together, our findings provide new insights into mutant BRAF-induced oncogenic stress that is manifested by DNA damage and growth arrest by activating the pCHK2-p53-p21 pathway in nontransformed cells, while it also confers tumor-promoting phenotypes such as the up-regulation of GLUT1 that contributes to enhanced glucose metabolism that characterizes tumor cells.",
author = "Sheu, {Jim Jinn Chyuan} and Bin Guan and Tsai, {Fuu Jen} and Hsiao, {Erin Yi Ting} and Chen, {Chih Mei} and Raquel Seruca and Tian-Li Wang and Shih, {Ie Ming}",
year = "2012",
month = "3",
doi = "10.1016/j.ajpath.2011.11.026",
language = "English (US)",
volume = "180",
pages = "1179--1188",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells

AU - Sheu, Jim Jinn Chyuan

AU - Guan, Bin

AU - Tsai, Fuu Jen

AU - Hsiao, Erin Yi Ting

AU - Chen, Chih Mei

AU - Seruca, Raquel

AU - Wang, Tian-Li

AU - Shih, Ie Ming

PY - 2012/3

Y1 - 2012/3

N2 - Although the oncogenic functions of activating BRAF mutations have been clearly demonstrated in human cancer, their roles in nontransformed epithelial cells remain largely unclear. Investigating the cellular response to the expression of mutant BRAF in nontransformed epithelial cells is fundamental to the understanding of the roles of BRAF in cancer pathogenesis. In this study, we used two nontransformed cyst108 and RK3E epithelial cell lines as models in which to compare the phenotypes of cells expressing BRAF WT and BRAF V600E. We found that transfection of the BRAF V600E, but not the BRAF WT, expression vector suppressed cellular proliferation and induced apoptosis in both cell types. BRAF V600E generated reactive oxygen species, induced DNA double-strand breaks, and caused subsequent DNA damage response as evidenced by an increased number of pCHK2 and γH2AX nuclear foci as well as the up-regulation of pCHK2, p53, and p21. Because BRAF and KRAS (alias Ki-ras) mutations have been correlated with GLUT1 up-regulation, which encodes glucose transporter-1, we demonstrated here that expression of BRAF V600E, but not BRAF WT, was sufficient to up-regulate GLUT1. Taken together, our findings provide new insights into mutant BRAF-induced oncogenic stress that is manifested by DNA damage and growth arrest by activating the pCHK2-p53-p21 pathway in nontransformed cells, while it also confers tumor-promoting phenotypes such as the up-regulation of GLUT1 that contributes to enhanced glucose metabolism that characterizes tumor cells.

AB - Although the oncogenic functions of activating BRAF mutations have been clearly demonstrated in human cancer, their roles in nontransformed epithelial cells remain largely unclear. Investigating the cellular response to the expression of mutant BRAF in nontransformed epithelial cells is fundamental to the understanding of the roles of BRAF in cancer pathogenesis. In this study, we used two nontransformed cyst108 and RK3E epithelial cell lines as models in which to compare the phenotypes of cells expressing BRAF WT and BRAF V600E. We found that transfection of the BRAF V600E, but not the BRAF WT, expression vector suppressed cellular proliferation and induced apoptosis in both cell types. BRAF V600E generated reactive oxygen species, induced DNA double-strand breaks, and caused subsequent DNA damage response as evidenced by an increased number of pCHK2 and γH2AX nuclear foci as well as the up-regulation of pCHK2, p53, and p21. Because BRAF and KRAS (alias Ki-ras) mutations have been correlated with GLUT1 up-regulation, which encodes glucose transporter-1, we demonstrated here that expression of BRAF V600E, but not BRAF WT, was sufficient to up-regulate GLUT1. Taken together, our findings provide new insights into mutant BRAF-induced oncogenic stress that is manifested by DNA damage and growth arrest by activating the pCHK2-p53-p21 pathway in nontransformed cells, while it also confers tumor-promoting phenotypes such as the up-regulation of GLUT1 that contributes to enhanced glucose metabolism that characterizes tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=84863152979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863152979&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2011.11.026

DO - 10.1016/j.ajpath.2011.11.026

M3 - Article

VL - 180

SP - 1179

EP - 1188

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -